Atossa Therapeutics, Inc. (ATOS) stock

ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30

$1.96+0.02 (+1.03%)

Close on Nov 13, 2026Market cap $19.56MP/E –Yield –

Atossa Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2015 it was -725746.2%, against -30323.0% the year before. The highest annual figure on record is -1052.0% in fiscal 2012.

Period	Period end	Value	Change (pts)
FY2015	Dec 31, 2015	-725746.2%	−695423.2
FY2014	Dec 31, 2014	-30323.0%	−28618.0
FY2013	Dec 31, 2013	-1704.9%	−652.9
FY2012	Dec 31, 2012	-1052.0%	+227560.7
FY2011	Dec 31, 2011	-228612.7%	–

See a number that looks wrong?